AVENUE THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q1 2017 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Avenue Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2017 to Q3 2024.
  • Avenue Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 11, 2024 was 1.91M shares, a 85.6% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.91M -11.3M -85.6% Nov 11, 2024 10-Q 2024-11-14
Q2 2024 1.43M -6.75M -82.5% Aug 7, 2024 10-Q 2024-08-09
Q1 2024 44.3M +38.3M +645% Mar 1, 2024 10-K 2024-03-18
Q3 2023 13.2M +8.47M +178% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 8.18M -14M -63% Aug 7, 2023 10-Q 2023-08-11
Q1 2023 5.94M -15.8M -72.6% Mar 28, 2023 10-K 2023-03-31
Q3 2022 4.77M -13.9M -74.5% Nov 1, 2022 10-Q 2022-11-10
Q2 2022 22.1M +5.39M +32.2% Aug 8, 2022 10-Q 2022-08-15
Q1 2022 21.7M +4.98M +29.8% Mar 21, 2022 10-K 2022-03-25
Q3 2021 18.7M +1.95M +11.7% Nov 12, 2021 10-Q 2021-11-15
Q2 2021 16.7M +45.3K +0.27% Aug 10, 2021 10-Q 2021-08-16
Q1 2021 16.7M +65.3K +0.39% Mar 17, 2021 10-K 2021-03-31
Q3 2020 16.7M +86.4K +0.52% Oct 28, 2020 10-Q 2020-11-04
Q2 2020 16.7M +143K +0.86% Aug 1, 2020 10-Q 2020-08-14
Q1 2020 16.7M +124K +0.75% Mar 29, 2020 10-K 2020-03-30
Q3 2019 16.7M +6M +56.3% Nov 1, 2019 10-Q 2019-11-13
Q2 2019 16.6M +6.01M +56.9% Aug 1, 2019 10-Q 2019-08-14
Q1 2019 16.6M +6.01M +56.9% Apr 30, 2019 10-Q 2019-05-13
Q4 2018 16.5M +6.23M +60.6% Feb 8, 2019 10-K 2019-03-12
Q3 2018 10.7M +397K +3.87% Nov 6, 2018 10-Q 2018-11-14
Q2 2018 10.6M +513K +5.11% Aug 6, 2018 10-Q 2018-08-14
Q1 2018 10.6M +529K +5.27% May 1, 2018 10-Q 2018-05-03
Q4 2017 10.3M Feb 14, 2018 10-K 2018-03-01
Q3 2017 10.3M Nov 2, 2017 10-Q 2017-11-09
Q2 2017 10M Aug 4, 2017 10-Q 2017-08-11
Q1 2017 10M May 4, 2017 10-Q 2017-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.